MRI scan to help test immunotherapy for gynecologic cancers
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This Phase 2 study uses a special MRI scan (hyperpolarized carbon-13) to look at how well immunotherapy works in gynecologic cancers. You may be able to help researchers better understand treatment response, if you meet the study health and scan-safety requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have gynecologic cancer that was newly diagnosed or has come back, confirmed by tissue biopsy results
- You are at least 20 years old
- Your cancer doctor expects you to start immunotherapy as part of your care plan
- You do not have other active cancers (except non-melanoma skin cancer)
- You do not have certain spleen problems, and your kidney, liver, and bone marrow functions are adequate
- You can safely complete MRI scans (for example, no pacemaker/unsafe metal in the pelvis, and you can tolerate enclosed spaces)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a combined PET and MRI scan to see if it can better identify the spread of cervical cancer before treatment. It may help guide more personalized care.
This early-phase study tests whether a special MRI scan with injected labeled “pyruvate” can act as a biomarker (a measurable sign) for advanced solid tumor activity. It may help doctors see tumor metabolism over time and better track how treatment is affecting cancer.
This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.
This trial uses a special MRI scan that shows how “metabolism” (how cells use fuel) differs in brain tumors. It may help researchers better understand tumor biology and how tumors may respond to treatment, without using chemotherapy or radiation as part of the study.
This Phase 1 study tests an investigational MRI scan (hpMRI) to help doctors see how thyroid cancer and other head-and-neck cancers respond to treatment like radiation or other medicines. If you’re eligible, the scan may help track treatment effects more closely, though it’s still being studied for this purpose.
This early study (Phase 1) tests a new kind of MRI that uses a special labeled sugar (pyruvate) to help learn how infiltrating gliomas behave in the brain. If you have a suspected or known infiltrating glioma and are having brain surgery or biopsy, this may help your doctors learn more about tumor metabolism and guide future care.
Hear when a new Gynecologic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.